Healthcare giant Johnson & Johnson is separating into two companies, one to focus on consumer products and another to handle its pharmaceuticals and medical devices.
The move comes as the company continues to grow and has gained worldwide attention for its single-shot COVID-19 vaccine.
Real journalism.Trusted by millions.
Unlimited access to in-depth reporting, expert analysis, and the stories that shape our country.
Subscribe Now
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.